The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Batycka Baran, A ^a   Maj, J ^a   Wolf, R ^b   Szepietowski, J C ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; ALPHA DEFENSIN; ALPHA INTERFERON; BETA INTERFERON; CALGRANULIN A; CALGRANULIN B; CALGRANULIN C; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLECALCIFEROL; DEFENSIN; FORMYLPEPTIDE RECEPTOR LIKE 1; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; KOEBNERISIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN S 100; PSORIASIN; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; CYTOKINE;

ADAPTIVE IMMUNITY; BODY MASS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; ESCHERICHIA COLI; GENE OVEREXPRESSION; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KERATINOCYTE; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTE; PLASMACYTOID DENDRITIC CELL; PROTEIN BLOOD LEVEL; PSORIASIS; REVIEW; T LYMPHOCYTE; UPREGULATION; BIOSYNTHESIS; CHEMOTAXIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LEUKOCYTE; PATHOLOGY; SKIN;

ADAPTIVE IMMUNITY; CATHELICIDINS; CHEMOTAXIS; CYTOKINES; DEFENSINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; KERATINOCYTES; LEUKOCYTES; PSORIASIS; S100 PROTEINS; SKIN;

EID: 84901777082     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/628289     Document Type: Review

References (87)

1. Nestle F. O., Kaplan D. H., Barker J., Mechanisms of disease: psoriasis. New England Journal of Medicine 2009 361 5 444 509 2-s2.0-68049131637 10.1056/NEJMra0804595
2. Tonel G., Conrad C., Interplay between keratinocytes and immune cells-Recent insights into psoriasis pathogenesis. International Journal of Biochemistry and Cell Biology 2009 41 5 963 968 2-s2.0-59649105640 10.1016/j.biocel.2008.10.022
3. Nickoloff B. J., Qin J.-Z., Nestle F. O., Immunopathogenesis of psoriasis. Clinical Reviews in Allergy and Immunology 2007 33 1-2 45 56 2-s2.0-39649113592 10.1007/s12016-007-0039-2 (Pubitemid 351514147)
4. Prinz J. C., From bench to bedside-translational research in psoriasis. Journal of the European Academy of Dermatology and Venereology 2010 24 supplement 6 1 4 2-s2.0-77956498691 10.1111/j.1468-3083.2010.03829.x
5. Girolomoni G., Mrowietz U., Paul C., Psoriasis: rationale for targeting interleukin-17. British Journal of Dermatology 2012 167 717 724 10.1111/j.1365-2133.2012.11099.x
6. Lowes M. A., Bowcock A. M., Krueger J. G., Pathogenesis and therapy of psoriasis. Nature 2007 445 7130 866 873 2-s2.0-33847279025 10.1038/nature05663
7. Albanesi C., De Pità O., Girolomoni G., Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clinics in Dermatology 2007 25 6 581 588 2-s2.0-36048944693 10.1016/j. clindermatol.2007.08.013 (Pubitemid 350087605)
8. Nestle F. O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., Burg G., Liu Y.-J., Gilliet M., Plasmacytoid predendritic cells initiate psoriasis through interferon- α production. Journal of Experimental Medicine 2005 202 1 135 143 2-s2.0-22344438901 10.1084/jem.20050500 (Pubitemid 41002916)
9. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.-H., Homey B., Cao W., Wang Y.-H., Su B., Nestle F. O., Zal T., Mellman I., Schröder J.-M., Liu Y.-J., Gilliet M., Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007 449 7162 564 569 2-s2.0-34948862264 10.1038/nature06116 (Pubitemid 47525141)
10. Frohm M., Agerberth B., Ahangari G., Ståhle-Bäckdahl M., Lidén S., Wigzell H., Gudmundsson G. H., The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. Journal of Biological Chemistry 1997 272 24 15258 15263 2-s2.0-0030956070 10.1074/jbc.272.24.15258 (Pubitemid 27255544)
11. Harder J., Schröder J.-M., Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. Journal of Leukocyte Biology 2005 77 4 476 486 2-s2.0-16844370194 10.1189/jlb.0704409 (Pubitemid 40489523)
12. Harder J., Bartels J., Christophers E., Schroder J.-M., A peptide antibiotic from human skin. Nature 1997 387 6636 861 2-s2.0-0030820726 10.1038/43088 (Pubitemid 27289577)
13. Madsen P., Rasmussen H. H., Leffers H., Honore B., Dejgaard K., Olsen E., Kiil J., Walbum E., Andersen A. H., Basse B., Lauridsen J. B., Ratz G. P., Celis A., Vandekerckhove J., Celis J. E., Molecular cloning, occurrence, and expression of a novel partially secreted protein "Psoriasin" that is highly up-regulated in psoriatic skin. Journal of Investigative Dermatology 1991 97 4 701 712 2-s2.0-0026042087
14. Wolf R., Mirmohammadsadegh A., Walz M., Lysa B., Tartler U., Remus R., Hengge U., Michel G., Ruzicka T., Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family. The FASEB Journal 2003 17 13 1969 1971
15. Morizane S., Gallo R. L., Antimicrobial peptides in the pathogenesis of psoriasis. Journal of Dermatology 2012 39 3 225 230 2-s2.0-84857536801 10.1111/j.1346-8138.2011.01483.x
16. Lai Y., Gallo R. L., AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends in Immunology 2009 30 3 131 141 2-s2.0-61349169039 10.1016/j.it.2008.12.003
17. Ong P. Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R. L., Leung D. Y. M., Endogenous antimicrobial peptides and skin infections in atopic dermatitis. New England Journal of Medicine 2002 347 15 1151 1160 2-s2.0-0037057645 10.1056/NEJMoa021481
18. Gallo R. L., Nizet V., Endogenous production of antimicrobial peptides in innate immunity and human disease. Current Allergy and Asthma Reports 2003 3 5 402 409 2-s2.0-0142058024 (Pubitemid 38899107)
19. Büchau A. S., Gallo R. L., Innate immunity and antimicrobial defense systems in psoriasis. Clinics in Dermatology 2007 25 6 616 624 2-s2.0-36048966235 10.1016/j.clindermatol.2007.08.016 (Pubitemid 350087608)
20. Nakatsuji T., Gallo R. L., Antimicrobial peptides: old molecules with new ideas. Journal of Investigative Dermatology 2012 132 3 887 895 2-s2.0-84856864352 10.1038/jid.2011.387
21. Risso A., Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. Journal of Leukocyte Biology 2000 68 6 785 792 2-s2.0-0033664277
22. Scott M. G., Hancock R. E. W., Cationic antimicrobial peptides and their multifunctional role in the immune system. Critical Reviews in Immunology 2000 20 5 407 431 2-s2.0-0034488452 (Pubitemid 32106684)
23. Oppenheim J. J., Yang D., Alarmins: chemotactic activators of immune responses. Current Opinion in Immunology 2005 17 4 359 365 2-s2.0-20544442905 10.1016/j.coi.2005.06.002 (Pubitemid 40848537)
24. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G. H., The human antimicrobial and chemotactic peptides LL-37 and α -defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000 96 9 3086 3093 2-s2.0-0034332193
25. Zanetti M., Gennaro R., Romeo D., Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Letters 1995 374 1 1 5 2-s2.0-0028844134 10.1016/0014-5793(95)01050-O
26. Zanetti M., Cathelicidins, multifunctional peptides of the innate immunity. Journal of Leukocyte Biology 2004 75 1 39 48 2-s2.0-0842326097 10.1189/jlb.0403147 (Pubitemid 38166778)
27. Zaiou M., Nizet V., Gallo R. L., Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. Journal of Investigative Dermatology 2003 120 5 810 816 2-s2.0-0037960231 10.1046/j.1523-1747.2003.12132.x (Pubitemid 36529083)
28. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R. A., Pestonjamasp V., Piraino J., Huttner K., Gallo R. L., Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001 414 6862 454 457 2-s2.0-0035936156 10.1038/35106587 (Pubitemid 34173727)
29. Larrick J. W., Lee J., Ma S., Li X., Francke U., Wright S. C., Balint R. F., Structural, functional analysis and localization of the human CAP18 gene. FEBS Letters 1996 398 1 74 80 2-s2.0-0030602220 10.1016/S0014-5793(96)01199-4 (Pubitemid 26400345)
30. Sørensen O. E., Follin P., Johnsen A. H., Calafat J., Sandra Tjabringa G., Hiemstra P. S., Borregaard N., Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001 97 12 3951 3959 2-s2.0-0035877995 10.1182/blood.V97.12. 3951
31. Zaiou M., Gallo R. L., Cathelicidins, essential gene-encoded mammalian antibiotics. Journal of Molecular Medicine 2002 80 9 549 561 2-s2.0-0036379140 10.1007/s00109-002-0350-6
32. Yamasaki K., Schauber J., Coda A., Lin H., Dorschner R. A., Schechter N. M., Bonnart C., Descargues P., Hovnanian A., Gallo R. L., Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. The FASEB Journal 2006 20 12 2068 2080 2-s2.0-33750139445 10.1096/fj.06-6075com (Pubitemid 44953906)
33. Dombrowski Y., Schauber J., Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis. Experimental Dermatology 2012 21 5 327 330 2-s2.0-84859896106 10.1111/j.1600-0625.2012.01459.x
34. Méndez-Samperio P., The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. Peptides 2010 31 9 1791 1798 2-s2.0-77955654919 10.1016/j.peptides.2010.06.016
35. Morizane S., Yamasaki K., Mühleisen B., Kotol P. F., Murakami M., Aoyama Y., Iwatsuki K., Hata T., Gallo R. L., Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. Journal of Investigative Dermatology 2012 132 1 135 143 2-s2.0-84856100861 10.1038/jid.2011.259
36. Braff M. H., Hawkins M. A., Di Nardo A., Lopez-Garcia B., Howell M. D., Wong C., Lin K., Streib J. E., Dorschner R., Leung D. Y. M., Gallo R. L., Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. Journal of Immunology 2005 174 7 4271 4278 2-s2.0-20144367318 (Pubitemid 40396008)
37. Mookherjee N., Brown K. L., Bowdish D. M. E., Doria S., Falsafi R., Hokamp K., Roche F. M., Mu R., Doho G. H., Pistolic J., Powers J.-P., Bryan J., Brinkman F. S. L., Hancock R. E. W., Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. Journal of Immunology 2006 176 4 2455 2464 2-s2.0-30044433704 (Pubitemid 43201696)
38. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S., A Toll-like receptor recognizes bacterial DNA. Nature 2000 408 6813 740 745 2-s2.0-0034619794 10.1038/35047123 (Pubitemid 32015992)
39. Ganguly D., Chamilos G., Lande R., Gregorio J., Meller S., Facchinetti V., Homey B., Barrat F. J., Zal T., Gilliet M., Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. Journal of Experimental Medicine 2009 206 9 1983 1994 2-s2.0-69549135324 10.1084/jem.20090480
40. Hänsel A., Günther C., Ingwersen J., Starke J., Schmitz M., Bachmann M., Meurer M., Rieber E. P., Schäkel K., Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses. Journal of Allergy and Clinical Immunology 2011 127 3 787 794 2-s2.0-79952309024 10.1016/j.jaci.2010.12.009
41. Chamilos G., Gregorio J., Meller S., Lande R., Kontoyiannis D. P., Modlin R. L., Gilliet M., Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood 2012 120 18 3699 3707 10.1182/blood-2012-01-401364
42. Chen X., Takai T., Xie Y., Niyonsaba F., Okumura K., Ogawa H., Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes. Biochemical and Biophysical Research Communications 2013 433 4 532 537 10.1016/j.bbrc.2013.03. 024
43. Chamorro C. I., Weber G., Grönberg A., Pivarcsi A., Ståhle M., The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. Journal of Investigative Dermatology 2009 129 4 937 944 10.1038/jid.2008.321
44. Zheng Y., Niyonsaba F., Ushio H., Nagaoka I., Ikeda S., Okumura K., Ogawa H., Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human α -defensins from neutrophils. British Journal of Dermatology 2007 157 6 1124 1131 2-s2.0-36148980891 10.1111/j.1365-2133.2007. 08196.x (Pubitemid 350115677)
45. De Yang B., Chen Q., Schmidt A. P., Anderson G. M., Wang J. M., Wooters J., Oppenheim J. J., Chertov O., LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. Journal of Experimental Medicine 2000 192 7 1069 1074 2-s2.0-0034596945 10.1084/jem.192.7.1069
46. Koczulla R., Von Degenfeld G., Kupatt C., Krötz F., Zahler S., Gloe T., Issbrücker K., Unterberger P., Zaiou M., Lebherz C., Karl A., Raake P., Pfosser A., Boekstegers P., Welsch U., Hiemstra P. S., Vogelmeier C., Gallo R. L., Clauss M., Bals R., An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. Journal of Clinical Investigation 2003 111 11 1665 1672 2-s2.0-0038142308 (Pubitemid 38057748)
47. Peric M., Koglin S., Kim S.-M., Morizane S., Besch R., Prinz J. C., Ruzicka T., Gallo R. L., Schauber J., IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. Journal of Immunology 2008 181 12 8504 8512 2-s2.0-58849143880
48. Peric M., Koglin S., Dombrowski Y., Groß K., Bradac E., Büchau A., Steinmeyer A., Zügel U., Ruzicka T., Schauber J., Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS ONE 2009 4 7 2-s2.0-67749111996 10.1371/journal.pone.0006340 e6340
49. Dombrowski Y., Peric M., Koglin S., Kammerbauer C., Göß C., Anz D., Simanski M., Gläser R., Harder J., Hornung V., Gallo R. L., Ruzicka T., Besch R., Schauber J., Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Science Translational Medicine 2011 3 82 2-s2.0-79955897768 10.1126/scitranslmed.3002001 82ra38
50. Kanda N., Ishikawa T., Kamata M., Tada Y., Watanabe S., Increased serum leucine, leucine-37 levels in psoriasis: positive and negative feedback loops of leucine, leucine-37 and pro- or anti-inflammatory cytokines. Human Immunology 2010 71 12 1161 1171 2-s2.0-78149409573 10.1016/j.humimm.2010.09.005
51. Al-Mutairi N., Shaaban D., Effect of narrowband ultraviolet B therapy on serum vitamin D and cathelicidin (LL-37) in patients with chronic plaque psoriasis. Journal of Cutaneous Medicine and Surgery 2014 18 1 43 48
52. Donato R., Intracellular and extracellular roles of S100 proteins. Microscopy Research and Technique 2003 60 6 540 551 2-s2.0-0142229704
53. Heizmann C. W., Fritz G., Schäfer B. W., S100 proteins: structure, functions and pathology. Frontiers in Bioscience 2002 7 d1356 d1368 2-s2.0-0036580943
54. Pietzsch J., S100 proteins in health and disease. Amino Acids 2011 41 4 755 760 2-s2.0-83255163189 10.1007/s00726-010-0816-8
55. Wolf R., Ruzicka T., Yuspa S. H., Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function. Amino Acids 2011 41 4 789 796 2-s2.0-83255186286 10.1007/s00726-010- 0666-4
56. Büchau A. S., Hassan M., Kukova G., Lewerenz V., Kellermann S., Würthner J. U., Wolf R., Walz M., Gallo R. L., Ruzicka T., S100A15, an antimicrobial protein of the skin: regulation by E. coli through toll-like receptor 4. Journal of Investigative Dermatology 2007 127 11 2596 2604 2-s2.0-35348903797 10.1038/sj.jid.5700946 (Pubitemid 47585068)
57. Zheng Y., Niyonsaba F., Ushio H., Ikeda S., Nagaoka I., Okumura K., Ogawa H., Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 2008 124 3 357 367 2-s2.0-44849110924 10.1111/j.1365-2567.2007.02782.x (Pubitemid 351793468)
58. Wolf R., Voscopoulos C. J., Fitzgerald P. C., Goldsmith P., Cataisson C., Gunsior M., Walz M., Ruzicka T., Yuspa S. H., The mouse S100A15 ortholog parallels genomic organization, structure, gene expression, and protein-processing pattern of the human S100A7/A15 subfamily during epidermal maturation. Journal of Investigative Dermatology 2006 126 7 1600 1608 2-s2.0-33745205312 10.1038/sj.jid.5700210
59. Wolf R., Lewerenz V., Büchau A. S., Walz M., Ruzicka T., Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium. Experimental Dermatology 2007 16 8 685 691 2-s2.0-34447503485 10.1111/j.1600-0625.2007.00587. x (Pubitemid 47079599)
60. Wolf R., Howard O. M. Z., Dong H.-F., Voscopoulos C., Boeshans K., Winston J., Divi R., Gunsior M., Goldsmith P., Ahvazi B., Chavakis T., Oppenheim J. J., Yuspa S. H., Chemotactic activity of S100A7 (psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. Journal of Immunology 2008 181 2 1499 1506 2-s2.0-49049094277
61. Wolf R., Mascia F., Dharamsi A., Howard O. M. Z., Cataisson C., Bliskovski V., Winston J., Feigenbaum L., Lichti U., Ruzicka T., Chavakis T., Yuspa S. H., Gene from a psoriasis susceptibility locus primes the skin for inflammation. Science Translational Medicine 2010 2 61 2-s2.0-78650183999 10.1126/scitranslmed.3001108 61ra90
62. Hegyi Z., Zwicker S., Bureik D., Peric M., Koglin S., Batycka-Baran A., Prinz J. C., Ruzicka T., Schauber J., Wolf R., Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 alarmins psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. Journal of Investigative Dermatology 2012 132 5 1416 1424 2-s2.0-84859754275 10.1038/jid.2011.486
63. Shubbar E., Vegfors J., Carlström M., Petersson S., Enerbäck C., Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Breast Cancer Research and Treatment 2011 134 1 71 80 2-s2.0-83655191207 10.1007/s10549-011-1920-5
64. Salama R. H., Al-Shobaili H. A., Al Robaee A. A., Alzolibani A. A., Psoriasin: a novel marker linked obesity with psoriasis. Disease Markers 2013 34 1 33 39 10.1155/2013/659864
65. Park S., Yoon S.-J., Tae H.-J., Shim C. Y., RAGE and cardiovascular disease. Frontiers in Bioscience 2011 16 2 486 497 2-s2.0-79955029506 10.2741/3700
66. Jabłońska S., Jarzabek-Chorzelska M., Maciejowska E., Rzesa G., Chorzelski T., Beutner E. H., Studies on the Koebner phenomenon. Archivum Immunologiae et Therapia Experimentalis 1978 26 1-6 775 778 (Pubitemid 9133504)
67. Madsen P., Rasmussen H. H., Leffers H., Honore B., Celis J. E., Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. Journal of Investigative Dermatology 1992 99 3 299 305 2-s2.0-0026778994
68. Nukui T., Ehama R., Sakaguchi M., Sonegawa H., Katagiri C., Hibino T., Huh N.-H., S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. Journal of Cellular Biochemistry 2008 104 2 453 464 2-s2.0-43449136180 10.1002/jcb.21639 (Pubitemid 351671635)
69. Kerkhoff C., Voss A., Scholzen T. E., Averill M. M., Zänker K. S., Bornfeldt K. E., Novel insights into the role of S100A8/A9 in skin biology. Experimental Dermatology 2012 21 11 822 826 10.1111/j.1600-0625.2012.01571.x
70. Benoit S., Toksoy A., Ahlmann M., Schmidt M., Sunderkötter C., Foell D., Pasparakis M., Roth J., Goebeler M., Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. British Journal of Dermatology 2006 155 1 62 66 2-s2.0-33745035454 10.1111/j.1365-2133.2006.07198.x (Pubitemid 43876394)
71. Lee Y., Jang S., Min J. K., Lee K., Sohn K. C., Lim J. S., Im M., Lee H. E., Seo Y. J., Kim C. D., Lee J. H., S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin. Biochemical and Biophysical Research Communications 2012 423 4 647 653 10.1016/j.bbrc.2012.05.162
72. Loser K., Vogl T., Voskort M., Lueken A., Kupas V., Nacken W., Klenner L., Kuhn A., Foell D., Sorokin L., Luger T. A., Roth J., Beissert S., The toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nature Medicine 2010 16 6 713 717 2-s2.0-77953233075 10.1038/nm.2150
73. Mirmohammadsadegh A., Tschakarjan E., Ljoljic A., Bohner K., Michel G., Ruzicka T., Goos M., Hengge U. R., Calgranulin C is overexpressed in lesional psoriasis. Journal of Investigative Dermatology 2000 114 6 1207 1208 2-s2.0-0034044101 10.1046/j.1523-1747.2000.00005-2.x (Pubitemid 30415242)
74. Harder J., Bartels J., Christophers E., Schröder J.-M., Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. Journal of Biological Chemistry 2001 276 8 5707 5713 2-s2.0-0035937107 10.1074/jbc.M008557200
75. Ryan L. K., Dai J., Yin Z., Megjugorac N., Uhlhorn V., Yim S., Schwartz K. D., Abrahams J. M., Diamond G., Fitzgerald-Bocarsly P., Modulation of human β -defensin-1 (HBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity. Journal of Leukocyte Biology 2011 90 2 343 356 2-s2.0-79961064178 10.1189/jlb.0209079
76. Zaalouk T. K., Bajaj-Elliott M., George J. T., McDonald V., Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infection and Immunity 2004 72 5 2772 2779 2-s2.0-2142653566 10.1128/IAI.72.5.2772-2779.2004 (Pubitemid 38542405)
77. Schroeder B. O., Wu Z., Nuding S., Groscurth S., Marcinowski M., Beisner J., Buchner J., Schaller M., Stange E. F., Wehkamp J., Reduction of disulphide bonds unmasks potent antimicrobial activity of human β 2-defensin 1. Nature 2011 469 7330 419 423 2-s2.0-78751653584 10.1038/nature09674
78. Liang S. C., Tan X.-Y., Luxenberg D. P., Karim R., Dunussi-Joannopoulos K., Collins M., Fouser L. A., Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. Journal of Experimental Medicine 2006 203 10 2271 2279 2-s2.0-33749318470 10.1084/jem.20061308 (Pubitemid 44498362)
79. Wang T.-T., Nestel F. P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J. H., Mader S., White J. H., Cutting edge: 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of Immunology 2004 173 5 2909 2912 2-s2.0-4344665018 (Pubitemid 39141992)
80. Schauber J., Dorschner R. A., Yamasaki K., Brouha B., Gallo R. L., Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 2006 118 4 509 519 2-s2.0-33746087225 10.1111/j.1365-2567.2006.02399.x (Pubitemid 44079569)
81. Hollox E. J., Huffmeier U., Zeeuwen P. L. J. M., Palla R., Lascorz J., Rodijk-Olthuis D., Van De Kerkhof P. C. M., Traupe H., De Jongh G., Heijer M. D., Reis A., Armour J. A. L., Schalkwijk J., Psoriasis is associated with increased β -defensin genomic copy number. Nature Genetics 2008 40 1 23 25 2-s2.0-37549033125 10.1038/ng.2007.48
82. Jansen P. A. M., Rodijk-Olthuis D., Hollox E. J., Kamsteeg M., Tjabringa G. S., de Jongh G. J., van Vlijmen-Willems I. M. J. J., Bergboer J. G. M., van Rossum M. M., de Jong E. M. G. J., den Heijer M., Evers A. W. M., Bergers M., Armour J. A. L., Zeeuwen P. L. J. M., Schalkwijk J., β -Defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS ONE 2009 4 3 2-s2.0-62749127946 10.1371/journal.pone.0004725 e4725
83. Niyonsaba F., Ushio H., Nakano N., Ng W., Sayama K., Hashimoto K., Nagaoka I., Okumura K., Ogawa H., Antimicrobial peptides human β -defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. Journal of Investigative Dermatology 2007 127 3 594 604 2-s2.0-33847040438 10.1038/sj.jid.5700599
84. Chen X., Niyonsoba F., Ushio H., Hara M., Yokoi H., Matsumoto K., Saito H., Nagaoka I., Ikeda S., Okumura K., Ogawa H., Antimicrobial peptides human β -defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. European Journal of Immunology 2007 37 2 434 444 2-s2.0-33947728599 10.1002/eji.200636379 (Pubitemid 46915583)
85. Niyonsaba F., Ushio H., Hara M., Yokoi H., Tominaga M., Takamori K., Kajiwara N., Saito H., Nagaoka I., Ogawa H., Okumura K., Antimicrobial peptides human β -defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. Journal of Immunology 2010 184 7 3526 3534 2-s2.0-77951626078 10.4049/jimmunol.0900712
86. Biragyn A., Ruffini P. A., Leifer C. A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A. K., Farber J. M., Segal D. M., Oppenheim J. J., Kwak L. W., Toll-like receptor 4-dependent activation of dendritic cells by β -defensin 2. Science 2002 298 5595 1025 1029 2-s2.0-0036829687 10.1126/science.1075565 (Pubitemid 35247310)
87. Tewary P., de la Rosa G., Sharma N., Rodriguez L. G., Tarasov S. G., Howard O. M., Shirota H., Steinhagen F., Klinman D. M., Yang D., Oppenheim J. J., β -Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN- α production by human plasmacytoid dendritic cells, and promote inflammation. The Journal of Immunology 2013 191 2 865 874 10.4049/jimmunol. 1201648